745
Participants
Start Date
May 20, 2019
Primary Completion Date
October 31, 2021
Study Completion Date
December 31, 2021
Endoscopic retrograde cholangiopancreatography (ERCP)
At the time of each ERCP procedure, information on procedure indication, technical performance of the duodenoscope and adverse events will be collected using a newly designed duodenoscope assessment tool. The duodenoscope assessment tool was developed to measure the technical performance of the duodenoscopes based on three components: passage and positioning at the papilla, performing requisite technical maneuvers and technical features. Each performance component is graded on a scale ranging from 1 to 5 (1 for easy maneuverability, 5 for most difficult maneuverability). Duodenoscope assessment tool also captures data on procedural indications, cannulation success rates and adverse events.
Mount Sinai Hospital, New York
Columbia University, New York
Allegheny Health, Pittsburgh
University of Florida, Gainesville
Center for Interventional Endoscopy, Orlando
Vanderbilt University, Nashville
University of Arkansas, Little Rock
Yale University, New Haven
Brigham and Women's Hospital, Boston
Lead Sponsor
AdventHealth
OTHER